Dr. Choueiri outlines the importance of experts putting their heads together to decide on how to approach gray areas. AUC3 will drive consensus on clinical guidelines that are vague about advanced kidney and bladder cancer treatments. Dr. Toni Choueiri looks forward to the interactive aspect of AUC3 for better decision-making in urologic cancers. Dr. Monty Pal is excited for AUC3 and establishing in-person consensus on new treatment options in urologic cancers. Drs. McKay and Rosenberg preview AUC3, the inaugural Advanced Urologic Cancer Consensus Conference. AUC3 seeks to reshape the landscape of GU cancer management through interdisciplinary dialogue and consensus building.